Dongwha Pharm has ranked among the top searched stocks on 4 days within the past month.

As of 10:36 AM on the 10th, Dongwha Pharm is trading at 16,150 KRW, up 0.31% from the previous day. This represents a 66.32% increase compared to May 21. Dongwha Pharm is known as a manufacturer and seller of pharmaceuticals such as Gas Hwal Myung Su and Fusidin.

Today, foreigners have net purchased 12,520 shares of Dongwha Pharm, and institutions have net purchased 35,000 shares, according to provisional data. Over the past 5 days, individual investors have net purchased 173,537 shares, while foreigners and institutions have net sold 53,400 shares and 15,175 shares, respectively.

On June 5, Dongwha Pharm became a market issue with an 18% rise on news of the "COVID-19 treatment 'animal testing imminent'."



[Table] Foreigners and Institutions Net Trading Volume (Unit: shares)
※Source: AI Investment Assistant AI Rassiro

※ This article was generated in real-time by an automatic article generation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.




This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing